<p>，/PRNewswire/ -- Fred Alger Management, LLC（&#34;Alger&#34;）是一傢俬人控股的成長型股權投資管理公司，今天宣佈了 Alger Russell 創新指數（&#34;指數&#34;）的季度再平衡。該指數將在 2025 年 12 月 19 日星期五交易結束後進行再平衡，以下變更將生效。</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>操作</strong></td>
<td><strong>公司名稱</strong></td>
<td><strong>股票代碼</strong></td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>CCC Intelligent Solutions Holdings, Inc.</td>
<td>CCC</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>Amdocs</td>
<td>DOX</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>Duolingo</td>
<td>DUOL</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>F5 Inc.</td>
<td>FFIV</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>GoDaddy</td>
<td>GDDY</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>Gentex Corp.</td>
<td>GNTX</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>Zebra Technologies</td>
<td>ZBRA</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Corcept Therapeutics Inc.</td>
<td>CORT</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Electronic Arts, Inc.</td>
<td>EA</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Gilead Sciences, Inc.</td>
<td>GILD</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Johnson &amp; Johnson</td>
<td>JNJ</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Qorvo, Inc.</td>
<td>QRVO</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>United Therapeutics Corp.</td>
<td>UTHR</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Vertex Pharmaceuticals Inc.</td>
<td>VRTX</td>
</tr>
</tbody>
</table>
<p>有關更多信息，請訪問 www.lseg.com。</p>
<p><strong>釋放您的成長潛力與 Alger</strong> 成立於 1964 年，Alger 被認為是成長型投資管理的先驅。Alger 是一傢俬人擁有的公司，總部位於紐約市，可以通過一系列成長型股權單獨賬户、共同基金、ETF 和私人投資工具來幫助您&#34;釋放您的成長潛力&#34;。Alger 的投資理念是發現經歷積極動態變化的公司，已有超過 60 年的歷史。有關更多信息，請訪問 www.alger.com。</p>
<p><strong>風險披露</strong>：投資於股市涉及風險，包括本金損失的潛在風險。成長型股票可能比其他股票更具波動性，因為它們的價格往往相對於公司的收益較高，並且可能對市場、政治和經濟發展更為敏感。地方、區域或全球事件，如環境或自然災害、戰爭、恐怖主義、流行病、傳染病爆發及類似公共衞生威脅、經濟衰退或其他事件，可能對投資產生重大影響。</p>
<p>本材料並不旨在提供投資建議，也不應被視為購買或出售證券的推薦。</p>
<p>Alger 向第三方營銷人員支付佣金，以向潛在投資者銷售各種策略。</p>
<p>倫敦證券交易所集團有限公司及其集團企業（統稱為&#34;LSE 集團&#34;）。© LSE 集團 2025 年。FTSE Russell 是某些 LSE 集團公司的交易名稱。&#34;FTSE®&#34; &#34;Russell®&#34;，&#34;FTSE Russell®&#34;是相關 LSE 集團公司的商標，並由任何其他 LSE 集團公司根據許可使用。FTSE Russell 指數或數據的所有權利歸擁有該指數或數據的相關 LSE 集團公司所有。LSE 集團及其許可方對指數或數據中的任何錯誤或遺漏不承擔任何責任，任何一方不得依賴本通信中包含的任何指數或數據。未經相關 LSE 集團公司的明確書面同意，不得進一步分發 LSE 集團的數據。LSE 集團不推廣、贊助或認可本通信的內容。</p>
<p>來源：Alger</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE1Jk5ld3NJdGVtSWQ9Tlk0NzgwNCZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTUxNjE4UFJfTkVXU19VU1BSX19fX19OWTQ3ODA0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE1Jk5ld3NJdGVtSWQ9Tlk0NzgwNCZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTUxNjE4UFJfTkVXU19VU1BSX19fX19OWTQ3ODA0"/></p>

CCCS

吉利德科學

聯合治療

Corcept醫療

藝電

<p>Fred Alger Management, LLC 宣佈阿爾傑羅素創新指數的季度再平衡，將於 2025 年 12 月 19 日交易結束後生效。新增成分股包括 CCC Intelligent Solutions、Amdocs、Duolingo、F5 Inc.、GoDaddy、Gentex Corp. 和 Zebra Technologies。剔除的成分股包括 Corcept Therapeutics、Electronic Arts、Gilead Sciences、Johnson & Johnson、Qorvo、United Therapeutics 和 Vertex Pharmaceuticals</p>

<p>, /PRNewswire/ -- Fred Alger Management, LLC (&#34;Alger&#34;), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index (&#34;Index&#34;). Following the close of trading on Friday, December 19, 2025, the Index will be rebalanced, and the following changes will be effective.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Fred Alger Management, LLC（&#34;Alger&#34;）是一傢俬人控股的成長型股權投資管理公司，今天宣佈了 Alger Russell 創新指數（&#34;指數&#34;）的季度再平衡。該指數將在 2025 年 12 月 19 日星期五交易結束後進行再平衡，以下變更將生效。</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Action</strong></td>
<td><strong>Company Name</strong></td>
<td><strong>Ticker Symbol</strong></td>
</tr>
<tr>
<td><strong>Addition</strong></td>
<td>CCC Intelligent Solutions Holdings, Inc.</td>
<td>CCC</td>
</tr>
<tr>
<td><strong>Addition</strong></td>
<td>Amdocs</td>
<td>DOX</td>
</tr>
<tr>
<td><strong>Addition</strong></td>
<td>Duolingo</td>
<td>DUOL</td>
</tr>
<tr>
<td><strong>Addition</strong></td>
<td>F5 Inc.</td>
<td>FFIV</td>
</tr>
<tr>
<td><strong>Addition</strong></td>
<td>GoDaddy</td>
<td>GDDY</td>
</tr>
<tr>
<td><strong>Addition</strong></td>
<td>Gentex Corp.</td>
<td>GNTX</td>
</tr>
<tr>
<td><strong>Addition</strong></td>
<td>Zebra Technologies</td>
<td>ZBRA</td>
</tr>
<tr>
<td><strong>Deletion</strong></td>
<td>Corcept Therapeutics Inc.</td>
<td>CORT</td>
</tr>
<tr>
<td><strong>Deletion</strong></td>
<td>Electronic Arts, Inc.</td>
<td>EA</td>
</tr>
<tr>
<td><strong>Deletion</strong></td>
<td>Gilead Sciences, Inc.</td>
<td>GILD</td>
</tr>
<tr>
<td><strong>Deletion</strong></td>
<td>Johnson &amp; Johnson</td>
<td>JNJ</td>
</tr>
<tr>
<td><strong>Deletion</strong></td>
<td>Qorvo, Inc.</td>
<td>QRVO</td>
</tr>
<tr>
<td><strong>Deletion</strong></td>
<td>United Therapeutics Corp.</td>
<td>UTHR</td>
</tr>
<tr>
<td><strong>Deletion</strong></td>
<td>Vertex Pharmaceuticals Inc.</td>
<td>VRTX</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>操作</strong></td>
<td><strong>公司名稱</strong></td>
<td><strong>股票代碼</strong></td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>CCC Intelligent Solutions Holdings, Inc.</td>
<td>CCC</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>Amdocs</td>
<td>DOX</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>Duolingo</td>
<td>DUOL</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>F5 Inc.</td>
<td>FFIV</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>GoDaddy</td>
<td>GDDY</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>Gentex Corp.</td>
<td>GNTX</td>
</tr>
<tr>
<td><strong>新增</strong></td>
<td>Zebra Technologies</td>
<td>ZBRA</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Corcept Therapeutics Inc.</td>
<td>CORT</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Electronic Arts, Inc.</td>
<td>EA</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Gilead Sciences, Inc.</td>
<td>GILD</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Johnson &amp; Johnson</td>
<td>JNJ</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Qorvo, Inc.</td>
<td>QRVO</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>United Therapeutics Corp.</td>
<td>UTHR</td>
</tr>
<tr>
<td><strong>刪除</strong></td>
<td>Vertex Pharmaceuticals Inc.</td>
<td>VRTX</td>
</tr>
</tbody>
</table>
</div><p>For additional information, please visit www.lseg.com.</p>
<div class="lb-trans"><p>有關更多信息，請訪問 www.lseg.com。</p>
</div><p><strong>Unlock Your Growth Potential with Alger</strong> Founded in 1964, Alger is recognized as a pioneer of growth-style investment management. Privately-owned and headquartered in New York City, Alger can help &#34;Unlock Your Growth Potential&#34; through a suite of growth equity separate accounts, mutual funds, ETFs, and privately offered investment vehicles. Alger's investment philosophy, discovering companies undergoing Positive Dynamic Change, has been in place for more than 60 years. For more information, please visit www.alger.com.</p>
<div class="lb-trans"><p><strong>釋放您的成長潛力與 Alger</strong> 成立於 1964 年，Alger 被認為是成長型投資管理的先驅。Alger 是一傢俬人擁有的公司，總部位於紐約市，可以通過一系列成長型股權單獨賬户、共同基金、ETF 和私人投資工具來幫助您&#34;釋放您的成長潛力&#34;。Alger 的投資理念是發現經歷積極動態變化的公司，已有超過 60 年的歷史。有關更多信息，請訪問 www.alger.com。</p>
</div><p><strong>Risk Disclosures</strong>: Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies' earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments.</p>
<div class="lb-trans"><p><strong>風險披露</strong>：投資於股市涉及風險，包括本金損失的潛在風險。成長型股票可能比其他股票更具波動性，因為它們的價格往往相對於公司的收益較高，並且可能對市場、政治和經濟發展更為敏感。地方、區域或全球事件，如環境或自然災害、戰爭、恐怖主義、流行病、傳染病爆發及類似公共衞生威脅、經濟衰退或其他事件，可能對投資產生重大影響。</p>
</div><p>This material is not meant to provide investment advice and should not be considered a recommendation to purchase or sell securities.</p>
<div class="lb-trans"><p>本材料並不旨在提供投資建議，也不應被視為購買或出售證券的推薦。</p>
</div><p>Alger pays compensation to third party marketers to sell various strategies to prospective investors.</p>
<div class="lb-trans"><p>Alger 向第三方營銷人員支付佣金，以向潛在投資者銷售各種策略。</p>
</div><p>London Stock Exchange Group plc and its group undertakings (collectively, the &#34;LSE Group&#34;). © LSE Group 2025. FTSE Russell is a trading name of certain of the LSE Group companies. &#34;FTSE®&#34; &#34;Russell®&#34;, &#34;FTSE Russell®&#34; are trade marks of the relevant LSE Group companies and are used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company's express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.</p>
<div class="lb-trans"><p>倫敦證券交易所集團有限公司及其集團企業（統稱為&#34;LSE 集團&#34;）。© LSE 集團 2025 年。FTSE Russell 是某些 LSE 集團公司的交易名稱。&#34;FTSE®&#34; &#34;Russell®&#34;，&#34;FTSE Russell®&#34;是相關 LSE 集團公司的商標，並由任何其他 LSE 集團公司根據許可使用。FTSE Russell 指數或數據的所有權利歸擁有該指數或數據的相關 LSE 集團公司所有。LSE 集團及其許可方對指數或數據中的任何錯誤或遺漏不承擔任何責任，任何一方不得依賴本通信中包含的任何指數或數據。未經相關 LSE 集團公司的明確書面同意，不得進一步分發 LSE 集團的數據。LSE 集團不推廣、贊助或認可本通信的內容。</p>
</div><p>SOURCE Alger</p>
<div class="lb-trans"><p>來源：Alger</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE1Jk5ld3NJdGVtSWQ9Tlk0NzgwNCZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTUxNjE4UFJfTkVXU19VU1BSX19fX19OWTQ3ODA0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY47804&amp;Transmission_Id=202512151618PR_NEWS_USPR_____NY47804&amp;DateId=20251215"/></p>

阿爾及爾羅素創新指數 2025 年第四季度更新